BioAdaptives
Health & Nutrition Products · Nevada, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2620 Regatta Dr Ste 102, Las Vegas, Neva...Phone Number
(702) 659-8829Website
www.bioadaptives.comRevenue
<$5 MillionStock Symbol
BDPTIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About BioAdaptives
BioAdaptives, Inc. manufactures and distributes natural plant- and algal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, anti-viral activity and immune system defense; resistance to stress; endurance; recovery from injury, illness and exercise; and anti-aging properties. The Company's current dietary supplement formulations are carefully selected from the best world-wide sources and utilize proprietary methods of enhancing the bioavailability of nutrients. The products for horses and dogs have also demonstrated increased general health, competitive performance enhancement, rejuvenation effects, and pain relief, as well as providing improvements in appearance. The company's current product line includes PrimiLungs, PrimiCell® and PluriPain® for humans and Canine Regen®, Equine Regen® and Equine All-in-One for dogs and horses. Additional human products, to be introduced soon, are designed to aid memory, cognition and focRead more
BioAdaptives Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioAdaptives your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when BioAdaptives launches new products
Congratulate Masked Content for being promoted to Masked Content at BioAdaptives
Check out if BioAdaptives is spiking on competitors!
Funding: Get notified immidiatlly once BioAdaptives has new funding data
Click to see if BioAdaptives had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
BioAdaptives, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on BioAdaptives recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if BioAdaptives has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to BioAdaptives
Compare insights from companies similar to BioAdaptives, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2011
JR
Joseph RousseauPresident of J & R and Chief Operating Officer of Scimera Bioscience
Company Profile Activity
Activity Insights
BioAdaptives is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioAdaptives is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioAdaptives.
BioAdaptives Tech Stack
A closer look at the technologies used by BioAdaptives
Most Recent Scoops
Project
Product Development, Product Management, Legal Affairs, Governmental Affairs & Regulation, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Lateral Move
Executive Move
Board of Directors
Lateral Move
Executive Move
Board of Directors
Executive Move
Board of Directors
BioAdaptives News & Media
BioAdaptives Announces XcellaraHeart Cardiovascular Wellness Formula Ahead of August Launch
BioAdaptives has introduced XcellaraHeart™, a new cardiovascular wellness supplement built on its Xcellara™ platform, with commercial availability scheduled to begin on August 1, 2026. Key Investor TakeawaysBioAdaptives (USOTC:BDPT) plans to launch XcellaraHeart™ on August 1, expanding its Xcellara™ supplement portfolio.BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells
The formula combines the Xcellara™ mobilization base with Tanshinone IIA, a Danshen-derived compound studied for its effects on the SDF-1α/CXCR4 signaling pathways involved in cellular trafficking and cardiovascular repair-response biology The formula combines the Xcellara™ mobilization base with Tanshinone IIA, a Danshen-derived compound studied for its effects on the SDF-1α/CXCR4 signaling pathways involved in cellular trafficking and cardiovascular repair-response biologyBioAdaptives director granted Series D preferred shares | BDPT Insider Trading - Stock Titan
BioAdaptives director Mark P. Frissora received 12,500 Series D preferred shares as board compensation, convertible into 1,250,000 common shares with a 4.9% ownership cap and 100 votes per share.BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity
Certification validates the complete day-and-night neuro-performance and repair system, positioning the company for broader adoption across elite sports and high-value consumer segments Certification validates the complete day-and-night neuro-performance and repair system, positioning the company for broader adoption across elite sports and high-value consumer segments
Read more news
Top Health & Nutrition Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioAdaptives
Sign Up For FreeTo access detailed company insights
BioAdaptives, Inc. manufactures and distributes natural plant- and algal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, anti-viral activity and immune system defense; resistance to stress; endurance; recovery from injury, illness and exercise; and anti-aging properties. The Compan... Read More
